Depletion of microbiome-derived molecules in the host using Clostridium genetics
Author(s) -
ChunJun Guo,
Breanna M. Allen,
Kamir J. Hiam-Galvez,
Dylan Dodd,
Will Van Treuren,
Steven K. Higginbottom,
Kazuki Nagashima,
Curt R. Fischer,
Justin L. Sonnenburg,
Matthew H. Spitzer,
Michael A. Fischbach
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aav1282
Subject(s) - clostridia , biology , clostridium , mutant , microbiome , microbiology and biotechnology , metabolite , bacteria , host (biology) , biochemistry , gene , genetics
Clostridial metabolite production The clostridia are Firmicute bacterial commensals commonly found in the mammalian gut. Clostridia produce a range of metabolites that diffuse into the host's circulation and have been difficult to manipulate genetically, but Guoet al. successfully developed a CRISPR-Cas9 deletion system inClostridium sporogenes (see the Perspective by Henke and Clardy). The authors used deletion mutants and mass spectrometry to elucidate clostridial synthesis of several different branched short-chain fatty acids (SCFAs), including isobutyrate, 2-methylbutyrate, and isovalerate. Germ-free mice colonized with mutants incapable of synthesizing SCFAs showed altered immunoglobulin A production. This finding potentially links bacterial SCFA production and host responses to the presence of the clostridia.Science , this issue p.eaav1282 ; see also p.1309
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom